Skip to main content
SpringerLink
Log in
Book cover

Brain Ischemia pp 105–119Cite as

Fibrinolysis and its Relevance to Acute Focal Cerebral Ischemia

  • Chapter

  • 247 Accesses

Abstract

The use of thrombolytic agents in the treatment of acute cerebral ischemia is experimental. Approximately 80%–90% of focal cerebral ischemic events presenting as strokes within 8–24 hours of symptom onset (Solis et al. 1977) and 50%–70% of all strokes prospectively entered in contemporary stroke registries (Mohr et al. 1978; Kunitz et al. 1984) are due to atherothrombotic and embolic occlusive disease. It is on this basis that efforts to evaluate the efficacy of thrombus lysis in acute stroke have attracted renewed interest.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abe T, Kazama M, Naito I et al. (1981a) Clinical evaluation for efficacy of tissue culture urokinase (TCUK) on cerebral thrombosis by means of multicenter double-bind study. Blood Vessels 12: 321 - 341

    Google Scholar 

  • Abe T, Kazawa M, Naito I (1981b) Clinical effect of urokinase (60 000 units/day) on cerebral infarction: comparative study by means of multiple-center double-blind test. Blood Vessels 12: 342–358

    Google Scholar 

  • Abe T, Terashi A, Tohgi H, Sasoh S, Naito I (1990) Clinical efficacy of intravenous administration of SM-9527 (t-PA) in cerebral thrombosis. Clin Eval 18: 39–69

    Google Scholar 

  • Adilgaard U (1969) Binding of thrombin to antithrombin III. Scand J Clin Lab Invest 24: 23–27

    Google Scholar 

  • Aldrich MS, Sherman SA, Greenberg HS (1985) Cerebrovascular complications of streptokinase infusion. JAMA 253: 1777–1779

    PubMed  CAS  Google Scholar 

  • Araki G, Minakami K, Mihara H (1973) Therapeutic effect of urokinase on cerebral infarction. Rinsho to Kenkyu 50: 3317–3326

    Google Scholar 

  • Astrup J, Symon L, Branston NM, Lassen N (1977) Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 8: 51–57

    PubMed  CAS  Google Scholar 

  • Atarashi J, Otomo E, Araki G, Itoh E, Togi H, Matsuda T (1985) Clinical utility of urokinase in the treatment of acute stage of cerebral thrombosis. Multicenter double-blind study in comparison with placebo. Clin Eval 13:659–709

    Google Scholar 

  • Atarashi J, Otomo E, Araki G, Itoh E, Togi H, Matsuda T (1985) Clinical utility of urokinase in the treatment of acute stage of cerebral thrombosis. Multicenter double-blind study in comparison with placebo. Clin Eval 13: 659–709

    Google Scholar 

  • Atkin N, Nitzberg S, Dorsey J (1964) Lysis of intracerebral thromboembolism with fibrinolysis Report of a case. Angiology 15: 346–439

    Google Scholar 

  • Babikian VL, Kase CS, Pessin MS, Norrving B, Gorelick PB (1989) Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke 29: 1500–1503

    Google Scholar 

  • Bach RR (1988) Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 23: 339–368

    PubMed  CAS  Google Scholar 

  • Bando H, Okada K, Matsuo O (1987) Thrombolytic effect of prourokinase in vitro. J Fibrinol 1: 169–176

    CAS  Google Scholar 

  • Bauer PI, Machovich R, Aranyi P, Buki KG, Csonke E, Horvath I (1983) Mechanism of thrombin binding to endothelial cells. Blood 61: 368–372

    PubMed  CAS  Google Scholar 

  • Berliner S, Niiya K, Roberts JR, Houghten RA, Ruggeri ZM (1988) Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein Ilb-IIIa without interacting with other adhesive molecules. J Biol Chem 263: 7500–7505

    PubMed  CAS  Google Scholar 

  • Bernick MB, Kwaan HC (1969) Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. J Clin Invest 48: 1740–1753

    Google Scholar 

  • Bloom AL, Thomas DP (eds) (1987) Haemostasis and thrombosis. Churchill Livingstone, Edinburgh

    Google Scholar 

  • Brogden RN, Speight TM, Avery GS (1973) Streptokinase: a review of its clinical pharmacology, mechanism of action, and therapeutic uses. Drugs 5: 357–445

    PubMed  CAS  Google Scholar 

  • Brott T, Haley C, Levy D et al. (1990) Safety and potential efficacy of tissue plasminogen activator (t-PA) for stroke. Stroke 21: 181

    Google Scholar 

  • Brott TG, Haley EC, Levy DE et al. (1992) Urgent therapy for stroke. Part I. Pilot study of tissue plaminogen activator administered within 90 minutes. Stroke 23: 632–640

    PubMed  CAS  Google Scholar 

  • Bruckmann H, Ferbert A (1989) Putaeminal hemorrhage after recanalization of an embolic MCA occlusion treated with tissue plasminogen activator. Neuroradiology 31: 95–97

    PubMed  CAS  Google Scholar 

  • Buteux G, Jubault V, Suisse A (1988) Local recombinant tissue plasminogen activator to clear cerebral artery thrombosis developing soon after surgery Lancet 1: 1143–1144

    Google Scholar 

  • Castellino FJ (1979) A unique enzyme-protein substrate modifier reaction: plasmin/streptokinase interaction. Trends Biochem Sci 4: 1–5

    CAS  Google Scholar 

  • Clarke RL, Cliffton EE (1960) The treatment of cerebrovascular thrombosis and embolism with fibrinolytic agents. Am J Cardiol 30: 546–551

    Google Scholar 

  • Collen D, Lijnen HR (1986) The fibrinolytic system in men. CRC Crit Rev Oncol Hematol 4: 249

    CAS  Google Scholar 

  • Collen D, Lijnen HR, Stassen JM (1992) Thrombolytic properties of staphylokinase and streptokinase in experimental animal models. Fibrinolysis 6 (Suppl 2): 29 (Abstract)

    Google Scholar 

  • Colucci M, Balconi G, Lorenzet R et al. (1983) Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71: 1893–1896

    PubMed  CAS  Google Scholar 

  • Comp PC, Jacocks RM, Ferrell GL, Esmon CT (1982) Activation of protein C in vivo. J Clin Invest 70: 127–134

    PubMed  CAS  Google Scholar 

  • Curtis CG (1987) Plasma factor XIII. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis. Churchill Livingstone, Edinburgh, p 217

    Google Scholar 

  • Dalai PM, Shah PM, Aiyar RR (1965a) Arteriographic study of cerebral embolism. Lancet 2: 358–361

    Google Scholar 

  • Dalai PM, Shah PM, Sheth SC, Deshparde CK (1965b) Cerebral embolism: angiographic observations on spontaneous clot lysis. Lancet 1: 61–64

    Google Scholar 

  • Damus PS, Hicks M, Rosenberg RD (1973) Anticoagulant action of heparin. Nature 246: 355–357

    PubMed  CAS  Google Scholar 

  • del Zoppo GJ (1988) Thrombolysis: new concepts in the treatment of stroke. In: Hennerici M, Sitzer G, Weger H-D (eds) Carotid artery plaques. Karger, Basel, pp 247–272

    Google Scholar 

  • del Zoppo GJ (1990) Relevance of focal cerebral ischemia models. Experience with fibrinolytic agents. Stroke 21: IV155–IV160

    Google Scholar 

  • del Zoppo GJ, Mori E (1992) Hematologic causes of intracerebral hemorrhage and their treatment. In: Batjer HH (ed) Spontaneous intracerebral hemorrhage. Neurosurg Clin North Am 3 (3): 637–658

    Google Scholar 

  • del Zoppo GJ, Zeumer H, Harker LA (1986a) Thrombolytic therapy in acute stroke: possibilities and hazards. Stroke 17: 595–607

    PubMed  Google Scholar 

  • del Zoppo GJ, Copeland BR, Waltz TZ, Tyroff J, Plow EF, Harker LA (1986b) The beneficial effect of intracarotid urokinase on acute stroke in a baboon model. Stroke 17: 638–643

    PubMed  Google Scholar 

  • del Zoppo GJ, Ferbert A, Otis S et al. (1988) Local intraarterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke 19: 307–313

    PubMed  Google Scholar 

  • del Zoppo GJ, Poeck K, Pessin MS et al. (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86

    PubMed  Google Scholar 

  • del Zoppo GJ, Mori E, Hacke W (1993) Thrombolytic therapy in acute ischemic stroke I I. Springer-Verlag, Heidelberg

    Google Scholar 

  • Drake ME, Shin C (1983) Conversion of ischemic to hemorrhagic infarction by anticoagulant administration. Report of two cases with evidence from serial computed tomographic brain scans. Arch Neurol 40: 44–46

    Google Scholar 

  • Drake TA, Hannani K, Fei H, Lavi S, Berliner JA (1991) Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 138: 601–607

    PubMed  CAS  Google Scholar 

  • Ehrlich HJ, Bang NW, Little SP et al. (1987) Biological properties of a kringleless tissue plasminogen activator (t-PA) mutant. Fibrinolysis 1: 75–81

    CAS  Google Scholar 

  • Fieschi C, Bozzao L (1969) Transient embolic occlusion of the middle cerebral and internal carotid arteries in cerebral apoplexy. J Neurol Neurosurg Psych 32: 236–240

    CAS  Google Scholar 

  • Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L (1989) Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 91: 311–321

    PubMed  CAS  Google Scholar 

  • Fisher CM, Adams RD (1951) Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 10: 92–94

    PubMed  CAS  Google Scholar 

  • Fisher CM, Adams RD (1987) Observations on brain embolism with special reference to hemorrhage infarction. In; Furlan AJ (ed) The heart and stroke. Exploring mutual cerebrovascular and cardiovascular issues. Springer-Verlag, New York, pp 17–36

    Google Scholar 

  • Fletcher AP, Alkjaersig N, Sherry S, Genton E, Hirsh J, Bachmann F (1965) The development of urokinase as a thrombolytic agent. Maintenance of a sustained thrombolytic state in man by its intravenous infusion. J Lab Clin Med 65: 713–731

    Google Scholar 

  • Fletcher AP, Alkjaersig N, Lewis M et al. (1976) A pilot study of urokinase therapy in cerebral infarction. Stroke 7: 135–142

    PubMed  CAS  Google Scholar 

  • Furlan AJ, Cavalier SJ, Hobbs RE, Weinstein MA, Modic MI (1982) Hemorrhage and anticoagulation after nonseptic embolic brain infarction. Neurology 32: 280–282

    PubMed  CAS  Google Scholar 

  • Gaffney PJ (1987) Fibrinolysis. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis. Churchill Livingstone, London, pp 223–244

    Google Scholar 

  • Gaffney PJ, Whittaker AN (1979) Fibrin cross-links and lysis rates. Thromb Res 14: 85–94

    PubMed  CAS  Google Scholar 

  • Gandell SJ (1992) Vampire bat salivary plasminogen activator (Bat-PA): exploration of efficacy and safety using animal models of arterial thrombosis and bleeding. Fibrinolysis 6 (Suppl 2): 28 (Abstract)

    Google Scholar 

  • Gheysen D, Lijnen HR, Pierard L et al. (1987) Characterization of a recombinant fusion protein of the kringle domain of tissue-type plasminogen activator with a truncated single chain urokinase type plasminogen activator. J Biol Chem 262: 11779–11784

    PubMed  CAS  Google Scholar 

  • Groskopf WR, Summaria L, Robbins KC (1969) Studies on the active center of human plasmin. Partial amino acid sequence of a peptide containing the active center serine residue. J Biol Chem 224: 3590

    Google Scholar 

  • Gunzler WA, Steffens GJ, Otting F, Buse G, Flohe L (1982) Structural relationship between human high and low molecular mass urokinase. Hoppe Seylers Z Physiol Chem 563: 133–141

    Google Scholar 

  • Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar oclusive disease. Stroke 19: 1216–1222

    PubMed  CAS  Google Scholar 

  • Haley EC, Levy DE, Brott TG et al. (1992) Urgent therapy for stroke. Part II. Pilot study of plasminogen administered 91-180 minutes from onset. Stroke 23: 641–645

    PubMed  Google Scholar 

  • Hanaway J, Torack R, Fletcher AP, Landau WM (1976) Intracranial bleeding associated with urokinase therapy for acute ischemic hemispheral stroke. Stroke 7: 143–146

    PubMed  CAS  Google Scholar 

  • Hart RG (1986) Cerebral Embolism Study Group: timing of hemorrhagic transformation of cardioembolic stroke. In: Stober T (ed) Central nervous system control of the heart. Martinus Nijhoff Publishing, Boston, pp 229–232

    Google Scholar 

  • Henze TH, Boeer A, Tebbe U, Romatowski J (1987) Lysis of basilar artery occlusion with tissue plasminogen activator. Lancet 1: 1391

    Google Scholar 

  • Herderschee D, Limburg U, Hijdra A, Koster PA (1991) Recombinant tissue plasminogen activator in two patients with basilar artery occlusion. J Neurol Neurosurg Psych 54: 71–73

    CAS  Google Scholar 

  • Herndon RM, Meyer JS, Johnson JF, Landers J (1960) Treatment of cerebrovascular thrombosis with fibrinolysin. Preliminary report. Am J Cardiol 30: 540–545

    Google Scholar 

  • Hornig CR, Dorndorf W, Agnoli AL (1986) Hemorrhagic cerebral infarction: a prospective study. Stroke 17: 179–185

    PubMed  CAS  Google Scholar 

  • Irino T, Taneda M, Minami T (1977) Angiographic manifestations in post-recanalized cerebral infarction. Neurology 27: 471–475

    PubMed  CAS  Google Scholar 

  • Ito Z, Suzuki A, Hen R, Menura K (1983) Prognostic factors in spontaneous recanalization of middle cerebral artery occlusion. In: Ito Z, Kutsuzawa T, Yasui N (eds) Cerebral ischemia-an update. Exerpta Medica, Amsterdam, pp 159–166

    Google Scholar 

  • Jacobson CD, Chandler AB (1965) Thrombolysis in vivo. I. Method, comparison of various thrombolytic agents and factors influencing thrombolysis. Scand J Clin Lab Invest 17 (Suppl 84): 209–224

    Google Scholar 

  • Koller RL (1982) Recurrent embolic cerebral infarction and anticoagulation. Neurology 32: 283–285

    PubMed  CAS  Google Scholar 

  • Koudstaal PJ, Stibbe J, Vermeulen M (1988) Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. Br Med J 297: 1571–1574

    CAS  Google Scholar 

  • Kruithoff EKO (1988) Inhibitors of plasminogen activators. In: Kluft C (ed) Tissue-type plasminogen activator (t-PA): physiological and clinical aspects. Volume 1. CRC Press, Boca Raton, pp 190–210

    Google Scholar 

  • Kruithof EKO, Tran-Thang C, Bachmann F (1986) The fastacting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase. Thromb Haemost 55: 65–69

    PubMed  CAS  Google Scholar 

  • Kruithof EKO, Tran-Thang C, Ransijn A, Bachmann R (1984) Demonstration of a fast acting inhibitor of plasminogen activators in human plasma. Blood 68: 907

    Google Scholar 

  • Kunitz SC, Gross CR, Heyman A et al. (1984) The pilot stroke data bank: definition, design and data. Stroke 15: 740–746

    PubMed  CAS  Google Scholar 

  • Levin EG, Loskutoff DJ (1982) Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 94: 631

    PubMed  CAS  Google Scholar 

  • Levin EG, Santell L (1987) Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells. J Cell Biol 105: 2543–2549

    PubMed  CAS  Google Scholar 

  • Levin EG, Santell L (1988) Stimulation and desensitization of tissue plasminogen activator release from human endothelial cells. J Biol Chem 263: 6502–6507

    Google Scholar 

  • Levin EG, Stern DM, Nawroth PP et al. (1986) Specificity of the thrombin-induced release of tissue plasminogen activator from cultured human endothelial cells. Thromb Haemost 56: 115–119

    PubMed  CAS  Google Scholar 

  • Lijnen HR, Zamarron C, Blaber M, Winkler ME, Collen D (1986) Activation of plasminogen by pro-urokinase. I. Mechanism. J Biol Chem 261: 1253–1258

    Google Scholar 

  • Lodder J, Krijne-Kubat B, van der Lugt PJM (1988) Timing of autopsy-confirmed hemorrhagic infarction with reference to cardioembolic stroke. Stroke 19: 1482–1484

    PubMed  CAS  Google Scholar 

  • Lollar P, Owen WG (1980) Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. J Clin Invest 66: 1222–1230

    PubMed  CAS  Google Scholar 

  • Majerus PW, Miletich JP, Kane WP, Hoffmann SL, Stanford N, Jackson CM (1980) The formation of thrombin on platelet surface. In: Mann KG, Taylor FB (eds) The regulation of coagulation. Elsevier/North Holland, New York, p 215

    Google Scholar 

  • Matsumoto K, Satoh K (1991) Topical intraarterial urokinase infusion for acute stroke. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer-Verlag, Heidelberg, pp 207–212

    Google Scholar 

  • Matsuo O, Collen D, Verstraete M (1981) On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921). Thromb Res 347: 358

    Google Scholar 

  • Meyer JS, Herndon RM, Gotoh F, Tazaki Y, Nelson JN, Johnson JF (1961) Therapeutic thrombolysis. In: Millikan CH, Siekert RG, Whisnant JP (eds) Cerebral vascular dis- Brain Ischemia: Basic Concepts and Clinical Relevance ease. Third Princeton Conference, Grune and Stratton, New York, pp 160–177

    Google Scholar 

  • Meyer JS, Gilroy J, Barnhart MI, Johnson JF (1963) Therapeutic thrombolysis in cerebral thromboembolism. Neurology 13: 927–937

    PubMed  CAS  Google Scholar 

  • Meyer JS, Gilroy J, Barnhart MI, Johnson JF (1964) Anticoagulants plus streptokinase therapy in progressive stroke. JAMA 189: 373

    PubMed  CAS  Google Scholar 

  • Miyakawa T (1984) The cerebral vessels and thrombosis. Rinsho Ketsueki 25: 1018–1026

    PubMed  CAS  Google Scholar 

  • Mobius E, Berg-Dammer E, Kiihne D, Ahser HC (1991) Local thrombolytic therapy in acute basilar artery occlusion: experience with 18 patients. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer-Verlag, Heidelberg, pp 213–215

    Google Scholar 

  • Mohr JP, Caplan LR, Melski JW et al. (1978) The Harvard Cooperative Stroke Registry: a prospective registry of patients hospitalized with stroke. Neurology 28: 754–762

    PubMed  CAS  Google Scholar 

  • Moncada S, Vane JR (1979) Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. New Engl J Med 300: 1142–1147

    PubMed  CAS  Google Scholar 

  • Mori E (1991) Fibrinolytic recanalization therapy in acute cerebrovascular thromboembolism. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer-Verlag, Heidelberg, pp 137–146

    Google Scholar 

  • Mori E, Tabuchi M, Yoshida T, Yamadori A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19: 802–812

    PubMed  CAS  Google Scholar 

  • Mori E, Yoneda Y, Ohkawa S et al. (1991) Double-blind placebo-controlled trial of intravenous recombinant tissue plasminogen activator (rt-PA) in acute carotid stroke. Neurology 41 (Suppl 1): 347

    Google Scholar 

  • Mori E, Yoneda Y, Tabuchi M et al. (1992) Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42: 976–982

    PubMed  CAS  Google Scholar 

  • Morrissey JH, Revak D, Tejada P, Fair DS, Edgington TS (1988) Resolution of monomeric and heterodimeric forms of tissue factor, the high affinity cellular receptor for factor VII. Thromb Res 50: 481–493

    PubMed  CAS  Google Scholar 

  • Mustard JF, Packham MA, Kinlough-Rathbone RL (1987) Mechanisms in thrombosis. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis, 2nd edn. Churchill Livingstone, Edinburgh, pp 618–650

    Google Scholar 

  • Nenci GG, Gresele P, Taramelli M, Agnelli G, Signorini E (1983) Thrombolytic therapy for thromboembolism of vertebrobasilar artery. Angiology 34: 561 - 571

    PubMed  CAS  Google Scholar 

  • Niemetz J (1972) Coagulant activity of monocytes. J Clin Invest 51: 307–313

    PubMed  CAS  Google Scholar 

  • Niemetz J, Morrison DC (1977) Lipid A as the biologically active moiety in bacterial endotoxin ( LPS)-initiated generation of procoagulant activity by peripheral blood leukocytes. Blood 49: 947–955

    Google Scholar 

  • Ogata J, Yutani C, Imakita M et al. (1989) Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke. Stroke 20: 876–883

    PubMed  CAS  Google Scholar 

  • Okada Y, Yamaguchi T, Minematsu K et al. (1989) Hemorrhagic transformation in cerebral embolism. Stroke 20: 598–603

    PubMed  CAS  Google Scholar 

  • Otomo E, Araki G, Itoh E, Tohgi H, Matsuda T, Atarashi J (1985) Clinical efficacy of urokinase in the treatment of cerebral thrombosis: multicenter double-blind study in comparison with placebo. Clin Eval 13: 711–751

    Google Scholar 

  • Otomo E, Tohgi H, Hirai S et al. (1988) Clinical efficacy of AK- 124 (tissue plasminogen activator) in the treatment of cerebral thrombosis: study by means of multicenter double blind comparison with urokinase. Yakuri To Chiryo 16: 3775–3821

    Google Scholar 

  • Ott BR, Zamani A, Kleefield J, Funkenstein HH (1986) The clinical spectrum of hemorrhagic infarction. Stroke 17: 630–637

    PubMed  CAS  Google Scholar 

  • Owren P (1944) New investigations on the coagulation of blood. Proc Norwegian Acad Sci 21

    Google Scholar 

  • Pelz P, Ladumer G, Giebritz E (1991) Neuropathological findings after thrombolytic therapy in acute ischemic stroke. In: Hacke W, del Zoppo GJ, Hirschberg M (eds)Thrombolytic therapy in acute ischemic stroke. Springer- Verlag, Heidelberg, pp 224–227

    Google Scholar 

  • Pessin MS, del Zoppo GJ, Estol CJ (1990) Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol 13: 271–289

    PubMed  CAS  Google Scholar 

  • Pessin MS, Teal PA, Caplan LR (1991) Hemorrhagic infarction: guilt by association. AJNR 12: 1123–1126

    PubMed  CAS  Google Scholar 

  • Pierard L, Jacobs P, Gheysen D et al. (1987) Mutant and chimeric recombinant plasminogen activators. J Biol Chem 262: 11771–11778

    PubMed  CAS  Google Scholar 

  • Ranby M, Bergsdorf N, Nilsson T (1982a) Enzymatic properties of the one- and two-chain form of tissue plasminogen activator. Thromb Res 27: 175–183

    PubMed  CAS  Google Scholar 

  • Ranby M, Bergsdorf N, Norrman B, Svenson E, Wallen P (1982b) Tissue plasminogen activator kinetics. In: Davison JF, Bachmann F, Bouvier CA, Kruithof EKO (eds) Progress in fibrinolysis. Volume VI. Churchill-Livingstone, New York, p 182

    Google Scholar 

  • Rickli EE (1975) The activation mechanism of human plasminogen. Thromb Diathes Haem 34: 386–395

    CAS  Google Scholar 

  • Rijken DC (1988) Structure/function relationships of t-PA. In: Kluft C (ed) Tissue type plasminogen activator (t-PA): physiological and clinical aspects. Volume 1. CRC Press, Boca Raton, pp 101–122

    Google Scholar 

  • Rijken DC, Hoylaerts M, Collen D (1982) Fibrinolytic properties of one-chain and two-chain human extrinsic (tissuetype) plasminogen activator. J Biol Chem 257: 2920–2925

    PubMed  CAS  Google Scholar 

  • Robbins KC, Summaria L, Hsieh B, Shah RJ (1967) The peptide chains of human plasmin. J Biochem 242: 2333–2342

    CAS  Google Scholar 

  • rt-PA Acute Stroke Study Group (1991) An open safety/ efficacy trial of rt-PA in acute thromboembolic stroke: final report. Stroke 22: 153

    Google Scholar 

  • Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR (1983) Platelets have more than one binding site for von Willebrand factor. J Clin Invest 72: 1–12

    PubMed  CAS  Google Scholar 

  • Runge MS, Bode C, Matsueda GR, Haber E (1987) Antibodyenhanced thrombolysis: targeting of tissue plasminogen activator in vivo. Proc Natl Acad Sci USA 84: 7659–7662

    PubMed  CAS  Google Scholar 

  • Savage B, Ruggeri ZM (1991) Selective recognition of adhesive sites in surface-bound fibrinogen by GPIIb-IIIa on nonactivated platelets. J Biol Chem 266: 11227–11233

    PubMed  CAS  Google Scholar 

  • Schwartz ML, Pizzo SV, Hill RL, McKee PA (1973) Human factor XIII from plasma and platelets. Molecular weight, subunit structures, proteolytic activation and cross-linking of fibrinogen and fibrin. J Biol Chem 248: 1395–1407

    Google Scholar 

  • Sjoholm I, Wiman B, Wallen P (1973) Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid. Eur J Biochem 39: 471–479

    PubMed  CAS  Google Scholar 

  • Skyhoj-Olsen T, Larsen B, Herring M, Skawer EB, Lassen NA (1983) Blood flow and vascular reactivity in collateral perfused brain tissue: evidence of an ischemic penumbra. Stroke 14: 332–341

    Google Scholar 

  • Smith RAG, Dupe RJ, English PD, Green J (1981) Fibrinolysis with acylenzymes: a new approach to thrombolytic therapy Nature 290: 505–508

    CAS  Google Scholar 

  • Smith RAG, Dupe FJ, English PD, Green J (1982) Acylenzymes as thrombolytic agents in a rabbit model of venous thrombosis. Thromb Haemost 47: 269–274

    PubMed  CAS  Google Scholar 

  • Solis OJ, Roberson GR, Taveras JM, Neohr J, Pessin M (1977) Cerebral angiography in acute cerebral infarction. Revist Interam Radiol 2: 19–25

    CAS  Google Scholar 

  • Stump DC, Mann KG (1988) Mechanisms of thrombus formation and lysis. Ann Emerg Med 17: 1138–1147

    PubMed  CAS  Google Scholar 

  • Sussman BJ, Fitch TSP (1958) Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA 167: 1705–1709

    CAS  Google Scholar 

  • Taneda M, Shimada N, Tsuchiya T (1985) Transient neurological deficits due to embolic occlusion and immediate reopening of the cerebral arteries. Stroke 16: 522–524

    PubMed  CAS  Google Scholar 

  • Theron J, Courtheoux P, Casaseo A et al. (1989) Local intraarterial fibrinolysis in the carotid territory. Am J Neuroradiol 10: 753–765

    PubMed  CAS  Google Scholar 

  • Thorsen S, Phillips M (1984) Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma: evidence for a rapid plasminogen activator inhibitor. Biochim Biophys Acta 802: 111

    PubMed  CAS  Google Scholar 

  • Verheijen JH, Chang GTG, Kluft C (1984) Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost 51: 392

    PubMed  CAS  Google Scholar 

  • Verstraete M, Collen D (1986) Thrombolytic therapy in the eighties. Blood 67: 1529–1541

    PubMed  CAS  Google Scholar 

  • von Kummer R (1991) Intravenous tissue plasminogen activator in acute stroke. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer-Verlag, Heidelberg, pp 161–167

    Google Scholar 

  • von Kummer R, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery. Stroke 23: 646–652

    Google Scholar 

  • White FW, Barlow GH, Mozen MM (1966) The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 5: 2160–2169

    PubMed  CAS  Google Scholar 

  • Wiman B, Chmielewska J, Ranby M (1984) Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor. J Biol Chem 259: 3644

    PubMed  CAS  Google Scholar 

  • Witt W, Baldus B, Bringmann P et al. (1992) The new plasminogen activators DSPAal and a2 from the vampire bat Desmodus rotundus. Fibrinolysis 6 (Suppl 2): 28 (Abstract)

    Google Scholar 

  • Yamaguchi T (1991) Intravenous rt-PA in acute embolic stroke. In: Hacke W, del Zoppo GJ, Hirschberg M (eds) Thrombolytic therapy in acute ischemic stroke. Springer- Verlag, Heidelberg, pp 168–174

    Google Scholar 

  • Yamaguchi T, Minematsu K, Choki J-I, Ikeda M (1984) Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction. Jpn Circ J 48: 50–58

    PubMed  CAS  Google Scholar 

  • Yamaguchi T, Hayaleawa T, Kileuchi H (1993) Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebo-controlled, double-blind trial. In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer-Verlag, Heidelberg, pp 59–65

    Google Scholar 

  • Zeumer H (1985) Survey of progress: vascular recanalizing techniques in interventional neuroradiology. J Neurol 231: 287–294

    PubMed  CAS  Google Scholar 

  • Zeumer H, Freitag HJ, Grzyka U, Neunzig HP (1989) Local intra-arterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology 31: 336–340

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. J. del Zoppo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, New England Medical Center Hospitals, 750 Washington Street, 02111, NEMCH #314, Boston, Massachusetts, USA

    Louis R. Caplan MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag London Limited

About this chapter

Cite this chapter

del Zoppo, G.J. (1995). Fibrinolysis and its Relevance to Acute Focal Cerebral Ischemia. In: Caplan, L.R. (eds) Brain Ischemia. Springer, London. https://doi.org/10.1007/978-1-4471-2073-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2073-5_14

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2075-9

  • Online ISBN: 978-1-4471-2073-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation